These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27593489)

  • 1. Nanoparticle-based B-cell targeting vaccines: Tailoring of humoral immune responses by functionalization with different TLR-ligands.
    Zilker C; Kozlova D; Sokolova V; Yan H; Epple M; Überla K; Temchura V
    Nanomedicine; 2017 Jan; 13(1):173-182. PubMed ID: 27593489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting and activation of antigen-specific B-cells by calcium phosphate nanoparticles loaded with protein antigen.
    Temchura VV; Kozlova D; Sokolova V; Uberla K; Epple M
    Biomaterials; 2014 Jul; 35(23):6098-105. PubMed ID: 24776487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation.
    Pitoiset F; Vazquez T; Levacher B; Nehar-Belaid D; Dérian N; Vigneron J; Klatzmann D; Bellier B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model.
    Silva JM; Zupancic E; Vandermeulen G; Oliveira VG; Salgado A; Videira M; Gaspar M; Graca L; Préat V; Florindo HF
    J Control Release; 2015 Jan; 198():91-103. PubMed ID: 25483429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation.
    Sokolova V; Knuschke T; Kovtun A; Buer J; Epple M; Westendorf AM
    Biomaterials; 2010 Jul; 31(21):5627-33. PubMed ID: 20417963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine.
    Sundararajan A; Sangster MY; Frey S; Atmar RL; Chen WH; Ferreira J; Bargatze R; Mendelman PM; Treanor JJ; Topham DJ
    Vaccine; 2015 Jan; 33(4):568-76. PubMed ID: 25444793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Tumor-Peptide-Based Nanoparticle Vaccine Elicits Efficient Tumor Growth Control in Antitumor Immunotherapy.
    Heße C; Kollenda S; Rotan O; Pastille E; Adamczyk A; Wenzek C; Hansen W; Epple M; Buer J; Westendorf AM; Knuschke T
    Mol Cancer Ther; 2019 Jun; 18(6):1069-1080. PubMed ID: 30962317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands-A Role for CCL2.
    Gomes AC; Mohsen MO; Mueller JE; Leoratti FMS; Cabral-Miranda G; Bachmann MF
    Front Immunol; 2019; 10():1679. PubMed ID: 31428084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
    Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
    Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands.
    Pavot V; Climent N; Rochereau N; Garcia F; Genin C; Tiraby G; Vernejoul F; Perouzel E; Lioux T; Verrier B; Paul S
    Biomaterials; 2016 Jan; 75():327-339. PubMed ID: 26539801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization.
    Fromen CA; Robbins GR; Shen TW; Kai MP; Ting JP; DeSimone JM
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):488-93. PubMed ID: 25548169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles.
    Sahu KK; Pandey RS
    Int Immunopharmacol; 2016 Oct; 39():343-352. PubMed ID: 27526270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.
    Ramani S; Neill FH; Ferreira J; Treanor JJ; Frey SE; Topham DJ; Goodwin RR; Borkowski A; Baehner F; Mendelman PM; Estes MK; Atmar RL
    Clin Vaccine Immunol; 2017 May; 24(5):. PubMed ID: 28249841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
    Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal IgG and IgA Antibodies Dampen Mucosal T Helper Cell Responses in Early Life.
    Koch MA; Reiner GL; Lugo KA; Kreuk LS; Stanbery AG; Ansaldo E; Seher TD; Ludington WB; Barton GM
    Cell; 2016 May; 165(4):827-41. PubMed ID: 27153495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
    Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B
    Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type of adjuvant strongly influences the T-cell response during nanoparticle-based immunization.
    Knuschke T; Epple M; Westendorf AM
    Hum Vaccin Immunother; 2014; 10(1):164-9. PubMed ID: 23982325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
    Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
    Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M-cell targeted polymeric lipid nanoparticles containing a Toll-like receptor agonist to boost oral immunity.
    Ma T; Wang L; Yang T; Ma G; Wang S
    Int J Pharm; 2014 Oct; 473(1-2):296-303. PubMed ID: 24984067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.